Tag: Illegal activities in pharma
Trump’s Anti-Bribery Law Pause: Impact on Pharma Behavior
Between 2011 and 2020, the world witnessed a staggering $1.34 billion in fines paid by the top pharmaceutical companies to the U.S. government for...
BREAKING NEWS
Eric Green Departure from National Human Genome Research Institute
Amidst the changing landscape of public health in America under the Trump administration, Eric Green, the longstanding director of the National Human Genome Research...
